Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-20

Clinical Trial Update: A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Candemore Plus Tab to Cantabell Tab for blood pressure lowering in patients with hypertension inadequately controlled on candesartan mon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candemore Plus Tab
  • Cantabell Tab

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 4 | Status: COMPLETED